| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69097-259-02 | 69097-259 | HUMAN PRESCRIPTION DRUG | SOLIFENACINE SUCCINATE | solifenacine succinate | TABLET | ORAL | 20190520 | N/A | ANDA | ANDA209839 | Cipla USA Inc. | SOLIFENACIN SUCCINATE | 5 mg/1 | 30 TABLET in 1 BOTTLE (69097-259-02) |
| 69097-259-05 | 69097-259 | HUMAN PRESCRIPTION DRUG | SOLIFENACINE SUCCINATE | solifenacine succinate | TABLET | ORAL | 20190520 | N/A | ANDA | ANDA209839 | Cipla USA Inc. | SOLIFENACIN SUCCINATE | 5 mg/1 | 90 TABLET in 1 BOTTLE (69097-259-05) |
| 69097-259-15 | 69097-259 | HUMAN PRESCRIPTION DRUG | SOLIFENACINE SUCCINATE | solifenacine succinate | TABLET | ORAL | 20190520 | N/A | ANDA | ANDA209839 | Cipla USA Inc. | SOLIFENACIN SUCCINATE | 5 mg/1 | 1000 TABLET in 1 BOTTLE (69097-259-15) |
| 69097-261-02 | 69097-261 | HUMAN PRESCRIPTION DRUG | SOLIFENACINE SUCCINATE | solifenacine succinate | TABLET | ORAL | 20190520 | N/A | ANDA | ANDA209839 | Cipla USA Inc. | SOLIFENACIN SUCCINATE | 10 mg/1 | 30 TABLET in 1 BOTTLE (69097-261-02) |
| 69097-261-05 | 69097-261 | HUMAN PRESCRIPTION DRUG | SOLIFENACINE SUCCINATE | solifenacine succinate | TABLET | ORAL | 20190520 | N/A | ANDA | ANDA209839 | Cipla USA Inc. | SOLIFENACIN SUCCINATE | 10 mg/1 | 90 TABLET in 1 BOTTLE (69097-261-05) |
| 69097-261-15 | 69097-261 | HUMAN PRESCRIPTION DRUG | SOLIFENACINE SUCCINATE | solifenacine succinate | TABLET | ORAL | 20190520 | N/A | ANDA | ANDA209839 | Cipla USA Inc. | SOLIFENACIN SUCCINATE | 10 mg/1 | 1000 TABLET in 1 BOTTLE (69097-261-15) |